How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | HUMHUMANA INC | UNHUNITEDHEALTH GROUP INC | ELVElevance Health, Inc. | CNCCENTENE CORP | Median of the restexcluding HUM |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $420.97▼ 4.45 (1.05%) | $424.98▲ 7.98 (1.91%) | $445.28▲ 11.15 (2.57%) | $71.24▲ 1.00 (1.42%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 6.0/10 | 6.0/10 | 6.0/10 | 4.7/10 | 6.0/10 |
| Market value | $50.79B | $385.03B | $98.28B | $35.03B | |
| Revenue | $129.66B | $447.57B | $199.13B | $174.58B | |
| Profit | $1.19B | $12.06B | $5.66B | -$6.67B | |
| Revenue growthChange in sales versus the prior year. | 10.1% | 11.8% | 12.5% | 20.0% | 12.5% |
| Gross marginShare of sales left after the direct cost of producing them. | — | 88.7% | 89.4% | 8.1% | 88.7% |
| Operating marginShare of sales left after running the business, before interest and tax. | 2.1% | 4.2% | 3.6% | -4.4% | 3.6% |
| Profit marginProfit kept from each dollar of sales. | 0.9% | 2.7% | 2.8% | -3.8% | 2.7% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 0.3% | 3.6% | 1.6% | 2.5% | 2.5% |
| Return on equityProfit against the owners' stake in the company. | 6.7% | 12.0% | 12.9% | -33.4% | 12.0% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 8.6% | 10.1% | 9.2% | -30.9% | 9.2% |
| P/E ratioPrice paid per dollar of annual profit. | 42.75x | 31.94x | 17.36x | — | 24.65x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 16.96x | 21.99x | 13.80x | — | 17.90x |
| Price to book | 2.88x | 3.85x | 2.24x | 1.76x | 2.24x |
| Debt to equityTotal liabilities compared with owners' stake. | 1.77x | 2.08x | 1.77x | 2.84x | 2.08x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 5/8 | 7/9 | 6/9 | 4/9 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | n/a for banks | n/a for banks | n/a for banks | n/a for banks |
How HUM compares with the others
- HUM's operating margin of 2.1% is lower than the median of the other companies selected (3.6%).
- Its revenue grew more slowly than the median of the other companies selected: 10.1% against 12.5%.
- It trades at a higher P/E than the median of the other companies selected: 42.8x against 24.6x.
- Its liabilities are lower relative to equity than the median of the other companies selected: 1.8x against 2.1x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.